Certain Class B Ordinary Shares of Oaktree Acquisition Corp. III Life Sciences are subject to a Lock-Up Agreement Ending on 22-APR-2025. These Class B Ordinary Shares will be under lockup for 181 days starting from 23-OCT-2024 to 22-APR-2025. Details: The company sponsor and our management team have agreed not to transfer, assign or sell any of their founder shares until the earliest of 180 days after the completion of initial business combination.